Notably, SP100 is responsible for the formation of PML nuclear bodies, predominantly serving as a suppressor of tumorigenesis across various cancer types, encompassing melanoma, glioblastoma, leiomyosarcoma, breast cancer, and laryngeal cancer (31–35). Here, SP100 is linked to glioblastoma.